Abbreviations AE: Adverse event BMI: Body mass index BP: Blood pressure CI: Confidence interval CV: Cardiovascular CVOT: Cardiovascular outcome trial DBP: Diastolic blood pressure ETD: Estimated treatment difference GIP: Glucose-dependent insulinotropic polypeptide GLP-1 RA: Glucagon-like peptide-1 receptor agonist HbA1c: Glycated haemoglobin A1c MACE-4: Major adverse cardiovascular events proAND: Pro-atrial natriuretic peptide SBP: Systolic blood pressure T2D: Type 2 diabetes WL-D: Weight-loss dependent WL-IND: Weight-loss independent References Petrie JR, Guzik TJ, Touyz RM
Along with increased physical activity and a reduced-calorie diet, Wegovy is FDA-approved for 2 indications: To reduce excess body weight and for long-term weight maintenance in adults and children age 12 or older with obesity, or in overweight adults with at least one weight-related condition such as heart disease, type 2 diabetes, or high blood pressure
Your results help your PlexusDx care team personalize not just your injection timing but your entire weight loss strategy based on your unique peptide pathways and metabolic responses
Ozempic Face is the gaunt, aged facial appearance caused by rapid facial fat loss during GLP-1 therapy
Always check with your doctor if you're allergic to sulfa
Silver City, NM: High-Lonesome Books